Associate Professor (Clinical) of Pathology, Division Medical Director, Genetics, Co-Program Director, Clinical Genetics Fellowship Program, Program Director, Molecular Genetics Fellowship Pr
BIOGRAPHY
AUG 22, 2013 10:00 AM PDT
Clinical Interpretation of Sequence Variants
Presented at:
Genetics and Genomics Virtual Event Series 2013
Speaker
Abstract
The advent of massively parallel sequencing by next generation sequencing platforms now allow genomic approaches for individualizing healthcare. Genomic sequencing data reveals variants in genes related to drug metabolism that may affect efficacy or response. This presentation will describe the potential of NGS data for companion diagnostics or therapeutics and its implementation into clinical laboratories. Evaluating pharmacogenetic targets through exome analysis as well as through targeted gene panels will be discussed.
You May Also Like
DEC 05, 2025 | 1:00 PM
C.E. CREDITS
Explore the evolution, methods, and limitations of mixing studies in detecting factor deficiencies and lupus anticoagulants in coagulation testing....
DEC 09, 2025 | 10:00 AM
Antibody-drug conjugates (ADCs) are transforming oncology by combining the precision of monoclonal antibodies with the potency of cytotoxic drugs. Yet, developing effective ADCs requires ove...
DEC 09, 2025 | 10:00 AM
Ensuring quality and compliance is at the core of every successful clinical laboratory. This webinar brings together CAP expert Daniel and Christie, QA leader from Burning Rock, to explore t...
DEC 10, 2025 | 2:00 PM
Colorectal cancer (CRC) is the second-leading cause of cancer-related deaths in Europe and the U.S.—yet when detected early, the 5-year survival rate jumps to 91% . While colonoscopy r...
DEC 10, 2025 | 8:00 AM
Mass spectrometry (MS)-based proteomic biomarker discovery pipeline commonly begins with large-scale profiling techniques detecting thousands of candidate biomarkers. Efficiently triaging th...
DEC 10, 2025 | 9:00 AM
BACKGROUND . Myelodysplastic syndromes (MDS) are a heterogeneous group of myeloid neoplasms with variable clinical outcomes and an increased risk of progression to Acute Myeloid Leukemia (AM...
Loading Comments...